ArticleAnnals of surgical oncology2026
The Effect of Pathologic Response to Preoperative Therapy on Margin Status and Outcomes After Resection of Colorectal Liver Metastases.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe prognostic value of the closest margin and margin of the largest tumor may depend on pathologic response to preoperative chemotherapy in colorectal liver metastases (CRLM). This study investigated the effect of margin status on overall survival (OS) stratified by pathologic response to preoperative chemotherapy. PATIENTS AND
methodsPatients with resected CRLM who received preoperative therapy were included. Responders were stratified by ≥ 75% pathologic response. R0 resection was defined as ≥ 1 mm margin. OS was calculated from the time of resection to last follow-up or death.
resultsBetween 1992 and 2016, 873 patients were identified (448 with multiple tumors). R1 resection occurred in 98 (11%) patients, and 227 (26%) were responders. With a median follow-up of 80 months, median OS between responders and nonresponders (92 [77, 156] versus 58 [52, 64], p < 0.001) and R1 and R0 resections (48 [35, 58] versus 68 [63, 78] months, p = 0.001) differed significantly. There was no difference in OS between R1 and R0 in the responder cohort (111 [78, 156] versus 72 [45, 180] months, p = 0.242), but there was a difference in the nonresponder cohort (40 [30, 49] versus 62 [54, 68] months, p < 0.001), where R1 remained an independent predictor of survival (HR 1.59 [1.16, 2.16], p = 0.004). In the multiple tumor cohort (n = 448), there was no difference in OS between R0 and R1 in the largest tumor (63 [55, 68] versus 46 [31, 58] months, p = 0.109).
conclusionsMargin status remains an important prognostic factor in CRLM. However, its prognostic significance is abrogated by response to preoperative chemotherapy. The largest tumor margin was not associated with survival, regardless of response.
Indexed as
Identifiers
41521372What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.